Cart
sales@molnova.com
Mosapride Citrate
CAS No. 112885-42-4
Mosapride Citrate( Mosapride Citrate )
Catalog No. M10452 CAS No. 112885-42-4
Mosapride Citrate is a gastroprokinetic agent that acts as a selective 5HT4 agonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 39 | In Stock |
|
| 25MG | 57 | In Stock |
|
| 50MG | 105 | In Stock |
|
| 100MG | 161 | In Stock |
|
| 200MG | 239 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMosapride Citrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionMosapride Citrate is a gastroprokinetic agent that acts as a selective 5HT4 agonist.
-
DescriptionMosapride Citrate is a gastroprokinetic agent that acts as a selective 5HT4 agonist.
-
In Vitro——
-
In Vivo——
-
SynonymsMosapride Citrate
-
PathwayEndocrinology/Hormones
-
Target5-HT Receptor
-
Recptor5-HT4
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number112885-42-4
-
Formula Weight614.02
-
Molecular FormulaC21H25ClFN3O3·C6H8O7
-
Purity>98% (HPLC)
-
SolubilityDMSO: 90 mg/mL (146.57 mM)
-
SMILESO=C(NCC1CN(CC2=CC=C(F)C=C2)CCO1)C3=CC(Cl)=C(N)C=C3OCC.OC(C(O)=O)(CC(O)=O)CC(O)=O
-
Chemical Name4-Amino-5-chloro-2-ethoxy-N-[[4-[(4-fluorophenyl)methyl]morpholin-2-yl]methyl]benzamide citrate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Nonogaki K, Kaji T. Diabetes Res Clin Pract. 2015 Dec;110(3):e18-2
molnova catalog
related products
-
Amperozide
Amperozide, a 5-HT2 antagonist, attenuates craving for cocaine by rats and reduces agonistic behaviors such as slashing and biting in pigs.
-
NGB2904 HCl
NGB2904 is a potent and selective antagonist of dopamine D3 receptor (Ki values are 1.4, 217, 223, 642, > 5000, > 10000 and > 10000 nM for D3, D2, 5-HT2, α1, D4, D1 and D5 receptors respectively).
-
LP-211
LP-211 is a brain penetrant selective agonist for a 5-HT7 receptor (Ki: 0.58 nM) and >300-fold selectivity over the 5-HT1A receptor.
